MedTrace Logo

Treatment of Screen-detected Celiac Disease

NCT01116505 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-08-27

No results posted yet for this study

Summary

The main purpose of this study is to evaluate the natural history of celiac disease in asymptomatic, screen-detected subjects having positive endomysial antibodies and the effects of an intervention with a gluten-free diet. The investigators hypothesize that these subjects may have decreased general health and benefit of the dietary treatment regardless of the small-bowel mucosal structure.

Conditions

Interventions

DIETARY_SUPPLEMENT

Gluten-free diet

gluten-containing cereals removed from diet

Sponsors & Collaborators

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Katri Kaukinen, MD · University of Tampere, Tampere University hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2012-07-31
Completion
2012-08-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01116505 on ClinicalTrials.gov